Paying user area
Try for free
Merck & Co. Inc. pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Assets
- Analysis of Geographic Areas
- Enterprise Value (EV)
- Enterprise Value to EBITDA (EV/EBITDA)
- Enterprise Value to FCFF (EV/FCFF)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Return on Assets (ROA) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Merck & Co. Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Adjusted Financial Ratios (Summary)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial ratios presented demonstrate varied trends over the five-year period. Generally, adjusted ratios show similar patterns to reported ratios, though with some magnitude differences, particularly in profitability metrics. Asset turnover and liquidity ratios exhibit relative stability, while leverage ratios fluctuate modestly. Profitability ratios, however, display more significant variations, especially in 2023.
- Asset Turnover
- Both reported and adjusted total asset turnover ratios increased from 2021 to 2023, peaking at 0.56 and 0.57 respectively, before declining slightly in 2024 and further in 2025. The adjusted ratio consistently remains marginally higher than the reported ratio, suggesting a potential impact from accounting adjustments related to asset valuation or categorization. The overall trend suggests a moderate efficiency in asset utilization, with a slight decrease in recent years.
- Liquidity
- The reported and adjusted current ratios both show an improvement from 2021 to 2022, followed by a decrease in 2023, and then a recovery through 2025. The adjusted current ratio consistently exceeds the reported ratio, indicating that adjustments tend to improve the short-term liquidity position. The ratios remain above 1.0 throughout the period, suggesting a generally healthy ability to meet short-term obligations.
- Leverage
- Reported debt to equity and debt to capital ratios decreased from 2021 to 2022, increased in 2023, and then decreased again in 2024, stabilizing in 2025. Adjusted ratios follow a similar pattern, with slightly lower values for debt to equity and debt to capital. Financial leverage mirrors this trend, with adjustments resulting in lower reported values. These fluctuations suggest changes in the company’s capital structure and reliance on debt financing.
- Profitability
- Reported net profit margin experienced a decline from 2021 to 2022, a substantial drop in 2023, and a strong recovery in 2024 and 2025. The adjusted net profit margin shows a similar pattern, but the impact of the 2023 decline is more pronounced, resulting in a negative value. This indicates that adjustments significantly affect reported earnings. Return on equity (ROE) and return on assets (ROA) follow a similar trajectory, with a significant decrease in 2023 and subsequent recovery. The adjusted ROE and ROA are notably impacted by the 2023 adjustments, showing negative values, while the reported values remain positive, albeit significantly reduced. The divergence between reported and adjusted profitability metrics in 2023 warrants further investigation.
In summary, the company demonstrates generally stable asset utilization and liquidity. Leverage ratios fluctuate, but remain within a reasonable range. The most significant variations are observed in profitability metrics, particularly in 2023, where adjustments have a substantial impact on reported earnings and returns. The consistent differences between reported and adjusted ratios suggest that accounting adjustments play a role in the company’s financial presentation.
Merck & Co. Inc., Financial Ratios: Reported vs. Adjusted
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
Total asset turnover = Sales ÷ Total assets
= ÷ =
2 Adjusted total assets. See details »
3 2025 Calculation
Adjusted total asset turnover = Sales ÷ Adjusted total assets
= ÷ =
Over the five-year period examined, sales demonstrated a generally increasing trajectory, rising from US$48,704 million in 2021 to US$65,011 million in 2025. Total assets exhibited a similar upward trend, although with more fluctuation, increasing from US$105,694 million in 2021 to US$136,866 million in 2025. Both the reported and adjusted total asset turnover ratios showed variability throughout the period, with some convergence in their patterns.
- Sales Trend
- Sales increased consistently year-over-year, with the most substantial growth occurring between 2021 and 2022 (a 21.7% increase). Growth rates moderated in subsequent years, ranging from approximately 1.6% to 8.1% annually. This suggests a maturing sales expansion.
- Total Asset Trend
- Total assets increased overall, but not uniformly. A slight decrease was observed between 2022 and 2023. The largest increase in total assets occurred between 2024 and 2025, rising by approximately 17.0%. This suggests potential investment in assets during that period.
- Reported Total Asset Turnover
- The reported total asset turnover ratio initially increased from 0.46 in 2021 to 0.56 in 2023, indicating improved efficiency in asset utilization. However, it then decreased to 0.55 in 2024 and further to 0.47 in 2025. This recent decline suggests a potential decrease in the efficiency with which assets are being used to generate sales.
- Adjusted Total Asset Turnover
- The adjusted total asset turnover ratio mirrored the trend of the reported ratio. It rose from 0.46 in 2021 to 0.57 in 2023, then decreased to 0.56 in 2024 and 0.48 in 2025. The adjusted ratio consistently remained slightly above or equal to the reported ratio throughout the period, indicating that the asset adjustments had a minimal impact on the overall turnover assessment. The decline in 2025 is notable, suggesting a similar weakening in asset utilization efficiency as observed in the reported ratio.
- Comparison of Reported and Adjusted Ratios
- The difference between the reported and adjusted total asset turnover ratios was minimal across all years. This indicates that the adjustments made to total assets did not significantly alter the overall assessment of how efficiently assets were being used to generate sales. The consistent patterns observed in both ratios suggest that the underlying drivers of asset turnover are similar, regardless of the adjustments.
Adjusted Current Ratio
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Adjusted current assets. See details »
3 2025 Calculation
Adjusted current ratio = Adjusted current assets ÷ Current liabilities
= ÷ =
The adjusted current ratio exhibits a generally increasing trend over the five-year period, though with some fluctuation. While closely mirroring the reported current ratio, the adjusted metric provides a slightly modified perspective on the company’s short-term liquidity position.
- Adjusted Current Ratio Trend
- The adjusted current ratio remained constant at 1.27 in 2021 and 2022. It then increased to 1.49 in 2022, before decreasing slightly to 1.28 in 2023. A further increase was observed in 2024, reaching 1.40, and continued upward in 2025 to 1.57. This suggests a strengthening ability to cover short-term liabilities with short-term assets over the period.
- Comparison to Reported Current Ratio
- The adjusted current ratio values are nearly identical to the reported current ratio values across all years. The difference between the two ratios is minimal, indicating that the adjustments made to current assets have a limited impact on the overall liquidity assessment. This suggests the adjustments are not materially altering the company’s short-term financial position.
- Underlying Asset and Liability Movements
- Both adjusted current assets and current liabilities generally increased over the period. Adjusted current assets rose from US$30,344 million in 2021 to US$44,525 million in 2025. Current liabilities also increased, but at a slower rate, moving from US$23,872 million in 2021 to US$28,327 million in 2025. The faster growth in adjusted current assets relative to current liabilities is the primary driver of the observed increase in the adjusted current ratio.
Overall, the adjusted current ratio indicates a stable to improving short-term liquidity position. The consistency between the reported and adjusted ratios suggests the adjustments are not fundamentally changing the assessment of the company’s ability to meet its short-term obligations.
Adjusted Debt to Equity
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
Debt to equity = Total debt ÷ Total Merck & Co., Inc. stockholders’ equity
= ÷ =
2 Adjusted total debt. See details »
3 Adjusted total equity. See details »
4 2025 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted total equity
= ÷ =
The adjusted debt to equity ratio for the period demonstrates fluctuations over the five-year span. Total debt exhibits an increasing trend, while total stockholders’ equity shows a more volatile pattern. These movements influence the adjusted debt to equity ratio, revealing shifts in the company’s financial leverage.
- Adjusted Debt to Equity Ratio - Overall Trend
- The adjusted debt to equity ratio begins at 0.83 in 2021, decreases to 0.66 in 2022, then increases to 0.96 in 2023. It subsequently declines to 0.84 in 2024 before stabilizing at 0.94 in 2025. This indicates a period of decreasing leverage followed by an increase, and then a slight decrease before ending at a level comparable to 2023.
- Debt and Equity Components
- Adjusted total debt generally increases throughout the period, rising from US$34,631 million in 2021 to US$50,534 million in 2025. Adjusted total equity also shows an overall upward trend, moving from US$41,721 million in 2021 to US$53,801 million in 2025, though it experiences a dip in 2023.
- Year-over-Year Changes
- The largest year-over-year increase in the adjusted debt to equity ratio occurs between 2022 and 2023, increasing from 0.66 to 0.96. This is concurrent with an increase in adjusted total debt and a decrease in adjusted total equity. A notable decrease in the ratio is observed between 2023 and 2024, from 0.96 to 0.84, driven by a smaller increase in adjusted total debt and a rise in adjusted total equity.
- Comparison to Reported Debt to Equity
- The adjusted debt to equity ratio closely mirrors the reported debt to equity ratio throughout the period. The differences between the two ratios are minimal in each year, suggesting that the adjustments made to total debt and equity do not significantly alter the overall leverage picture. Both ratios show similar trends and magnitudes.
In summary, the company’s financial leverage, as indicated by the adjusted debt to equity ratio, has experienced moderate fluctuations. While debt has generally increased, equity has also grown, resulting in a ratio that remains relatively stable overall, with a peak in 2023.
Adjusted Debt to Capital
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =
2 Adjusted total debt. See details »
3 Adjusted total capital. See details »
4 2025 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= ÷ =
The information presents a five-year trend of debt and capital figures, culminating in adjusted debt-to-capital ratios. Total debt exhibited a decrease from 2021 to 2022, followed by increases in subsequent years, reaching 49,339 US$ millions in 2025. Total capital generally increased over the period, moving from 71,286 US$ millions in 2021 to 101,945 US$ millions in 2025, with a slight dip observed between 2022 and 2023.
- Reported Debt to Capital
- The reported debt-to-capital ratio began at 0.46 in 2021, decreased to 0.40 in 2022, and then fluctuated around the 0.44 to 0.48 range for the remaining years. The ratio demonstrates relative stability after the initial decline, ending at 0.48 in 2025.
- Adjusted Total Debt
- Adjusted total debt mirrored the trend of total debt, decreasing from 34,631 US$ millions in 2021 to 31,985 US$ millions in 2022, and then increasing to 50,534 US$ millions by 2025. The magnitude of the increase from 2023 to 2025 is notably larger than previous annual changes.
- Adjusted Total Capital
- Adjusted total capital followed a similar pattern to total capital, increasing from 76,352 US$ millions in 2021 to 104,335 US$ millions in 2025. A slight decrease was noted between 2022 and 2023, but the overall trend is upward. The increase from 2024 to 2025 is substantial.
- Adjusted Debt to Capital
- The adjusted debt-to-capital ratio began at 0.45 in 2021, decreased to 0.40 in 2022, and then increased to 0.49 in 2023. It subsequently decreased slightly to 0.46 in 2024 before stabilizing at 0.48 in 2025. The ratio’s movement closely parallels that of the reported debt-to-capital ratio, suggesting the adjustments applied do not significantly alter the overall leverage picture. The ratio remained relatively stable between 0.45 and 0.49 throughout the observed period.
In summary, while both total and adjusted debt increased over the five-year period, the corresponding increases in total and adjusted capital resulted in a relatively stable debt-to-capital ratio. The most significant increases in both debt and capital occurred between 2024 and 2025.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
Financial leverage = Total assets ÷ Total Merck & Co., Inc. stockholders’ equity
= ÷ =
2 Adjusted total assets. See details »
3 Adjusted total equity. See details »
4 2025 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted total equity
= ÷ =
The financial leverage of the company, as measured by adjusted financial ratios, exhibits a generally stable pattern over the five-year period from 2021 to 2025. Total assets demonstrate an overall increasing trend, though with a slight decrease between 2022 and 2023, before resuming growth through 2025. Total stockholders’ equity also generally increases, mirroring the trend in assets, with a similar dip between 2022 and 2023. The adjusted figures for both assets and equity show similar patterns to their reported counterparts.
- Adjusted Financial Leverage – Overall Trend
- Adjusted financial leverage decreased from 2.52 in 2021 to a low of 2.26 in 2022. It then increased to 2.78 in 2023, followed by a slight decrease to 2.51 in 2024 and remained constant at 2.51 in 2025. This suggests a period of deleveraging followed by a moderate increase in leverage, stabilizing in the most recent year.
- Adjusted Financial Leverage – Comparison to Reported Leverage
- Reported financial leverage generally follows the same trend as the adjusted ratio, starting at 2.77 in 2021, decreasing to 2.37 in 2022, increasing to 2.84 in 2023, and decreasing to 2.53 in 2024, before reaching 2.60 in 2025. The adjusted leverage consistently reports lower values than the reported leverage across all years, indicating that the adjustments made to total assets and equity result in a more conservative leverage position.
- Asset and Equity Movements
- Both adjusted total assets and adjusted total equity experienced growth from 2021 to 2025. The increase in assets was more pronounced, particularly between 2024 and 2025, growing from US$114,434 million to US$135,270 million. Adjusted total equity also increased steadily, from US$41,721 million in 2021 to US$53,801 million in 2025. The relative growth in assets compared to equity contributes to the observed fluctuations in the leverage ratio.
The observed patterns suggest the company maintains a relatively stable financial leverage position, with adjustments to asset and equity values resulting in a slightly more conservative leverage profile. The increase in both assets and equity over the period indicates overall financial growth, while the stabilization of the adjusted leverage ratio in the final year suggests a deliberate management of the company’s capital structure.
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
Net profit margin = 100 × Net income attributable to Merck & Co., Inc. ÷ Sales
= 100 × ÷ =
2 Adjusted net income. See details »
3 2025 Calculation
Adjusted net profit margin = 100 × Adjusted net income ÷ Sales
= 100 × ÷ =
The adjusted net profit margin exhibited considerable fluctuation over the five-year period. Initial values were strong, followed by a significant decline, and then a recovery towards the end of the period. A detailed examination of the trends is presented below.
- Adjusted Net Profit Margin - Overall Trend
- The adjusted net profit margin began at 29.32% in 2021, decreased substantially to 21.56% in 2022, and experienced a marked decline to -2.38% in 2023. A strong recovery was then observed, with the margin increasing to 25.29% in 2024 and further to 27.78% in 2025. This indicates a period of profitability challenges in 2023, followed by a return to more favorable performance.
- Relationship to Adjusted Net Income
- The negative adjusted net profit margin in 2023 directly corresponds with a negative adjusted net income of US$ -1,431 million. This suggests substantial headwinds or unusual expenses impacted profitability during that year. Conversely, the increasing adjusted net profit margin in 2024 and 2025 aligns with increasing adjusted net income values of US$ 16,231 million and US$ 18,062 million, respectively.
- Comparison with Reported Net Profit Margin
- The adjusted net profit margin consistently differed from the reported net profit margin. The largest discrepancy occurred in 2023, where the reported margin was 0.61% while the adjusted margin was -2.38%. This substantial difference suggests significant adjustments were made to net income in 2023, likely related to non-recurring items or specific accounting treatments. The adjusted margin generally remained higher than the reported margin in 2021 and 2022, but converged towards similar levels in 2024 and 2025.
- Sales Trend and Margin Impact
- Sales demonstrated a consistent upward trend throughout the period, increasing from US$ 48,704 million in 2021 to US$ 65,011 million in 2025. However, the increase in sales did not consistently translate into improved profitability, as evidenced by the decline in adjusted net profit margin in 2022 and particularly in 2023. The recovery in margin in 2024 and 2025 suggests improved cost management or pricing strategies alongside continued sales growth.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
ROE = 100 × Net income attributable to Merck & Co., Inc. ÷ Total Merck & Co., Inc. stockholders’ equity
= 100 × ÷ =
2 Adjusted net income. See details »
3 Adjusted total equity. See details »
4 2025 Calculation
Adjusted ROE = 100 × Adjusted net income ÷ Adjusted total equity
= 100 × ÷ =
The reported return on equity (ROE) exhibited volatility over the five-year period. Initially strong at 34.17% in 2021, it decreased to 31.57% in 2022 before experiencing a substantial decline to 0.97% in 2023. A recovery was observed in 2024, with ROE reaching 36.96%, followed by a slight decrease to 34.70% in 2025. The adjusted ROE mirrored this trend, though with differing magnitudes in certain years.
- Adjusted ROE Trend
- The adjusted ROE began at 34.23% in 2021, slightly above the reported ROE. It then decreased more significantly in 2022 to 26.50%. A marked shift occurred in 2023, with the adjusted ROE becoming negative at -3.78%, a considerably larger decline than the reported ROE. The adjusted ROE rebounded strongly in 2024 to 35.55%, and continued to 33.57% in 2025.
The divergence between reported and adjusted ROE is most pronounced in 2023. While the reported ROE remained positive, albeit low, the adjusted ROE turned negative. This suggests that adjustments made to net income and total equity had a substantial adverse impact on the calculated return in that year. The adjustments appear to have lessened the volatility observed in the reported ROE, particularly in 2022 and 2024.
- Net Income and Equity Adjustments
- Adjusted net income was consistently higher than reported net income in 2021 and 2022, but significantly lower in 2023 and 2024. The negative adjusted net income in 2023 is a key driver of the negative adjusted ROE. Adjusted total equity generally tracked reported equity, with adjustments resulting in slightly higher values in 2021 and 2022, and similar values in 2023, 2024 and 2025.
The fluctuations in adjusted ROE, particularly the negative value in 2023, warrant further investigation into the nature of the adjustments made to net income and equity. The relatively stable adjusted equity suggests that the primary driver of the adjusted ROE changes is the adjusted net income.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
1 2025 Calculation
ROA = 100 × Net income attributable to Merck & Co., Inc. ÷ Total assets
= 100 × ÷ =
2 Adjusted net income. See details »
3 Adjusted total assets. See details »
4 2025 Calculation
Adjusted ROA = 100 × Adjusted net income ÷ Adjusted total assets
= 100 × ÷ =
The adjusted return on assets (ROA) exhibited fluctuations over the five-year period. While generally remaining in positive territory, a notable decline and subsequent recovery are observed. A review of the underlying components – adjusted net income and adjusted total assets – provides further insight into these movements.
- Adjusted ROA Trend
- The adjusted ROA began at 13.59% in 2021, decreased to 11.72% in 2022, and experienced a significant drop to -1.36% in 2023. A substantial recovery followed, with the adjusted ROA rising to 14.18% in 2024 and stabilizing at 13.35% in 2025.
- Adjusted Net Income Influence
- Adjusted net income generally increased from US$14,282 million in 2021 to US$18,062 million in 2025. However, a significant decrease to a loss of US$-1,431 million occurred in 2023, directly contributing to the negative adjusted ROA for that year. The recovery in 2024 and 2025 aligns with the increase in adjusted net income.
- Adjusted Total Assets Influence
- Adjusted total assets demonstrated a consistent upward trend throughout the period, increasing from US$105,080 million in 2021 to US$135,270 million in 2025. This growth in the asset base, while generally positive, partially offset the positive impact of increasing adjusted net income, particularly in 2024 and 2025, moderating the ROA increase.
The substantial volatility in adjusted net income appears to be the primary driver of the fluctuations in adjusted ROA. While asset growth is consistent, the impact of net income swings is more pronounced. The negative adjusted ROA in 2023 highlights the sensitivity of this metric to profitability.
- Comparison to Reported ROA
- The adjusted ROA generally differs from the reported ROA, suggesting the presence of items impacting net income or asset values that are being adjusted for. The largest discrepancy is observed in 2023, where the reported ROA is 0.34% while the adjusted ROA is -1.36%, indicating significant adjustments were made to arrive at the adjusted figure.